The rebirth of pancreas transplantation: an innovative, fully robotic, reproducible surgical technique Authors: Phillipe Abreu, Haaris Kadri, Simone Zaragoza, Giselle Guerra, Mariella Ortigosa-Goggins, Michelle C Nguyen, Adeel S Khan, Mohamed Eltemamy, Juliano Riella, Jose Figueiro, Rodrigo Vianna, Dieter Broering, Ugo Boggi, Mario Spaggiari Published: 2026 ABSTRACT AbstractBackgroundPancreas transplantation remains the only definitive therapy for restoring endogenous insulin secretion and physiologic glycemic control in patients with insulin-dependent diabetes mellitus. Utilization in the United States has declined, however, in part due to morbidity associated with open simultaneous pancreas-kidney transplantation (SPKT), secondary to the incision or bowel manipulation, and procedural concentration within high-volume centers. The dissemination of robotic kidney transplantation has demonstrated the feasibility of minimally invasive transplant surgery and provides a platform to reconsider pancreas transplantation using standardized robotic principles.MethodsWe describe a reproducible technique for robotic pancreas transplantation (RPT), applicable to SPKT, pancreas-after-kidney transplantation, and pancreas-transplant-alone. Patient selection follows established criteria with multidisciplinary evaluation and preoperative vascular imaging. The operative workflow includes back-table vascular construction, limited iliac vessel dissection, extraperitoneal graft placement in a head-down orientation on the left iliac fossa, tension-free portal vein anastomosis to the external iliac vein, arterial anastomosis to the external iliac artery, controlled reperfusion, and side-to-side duodeno-ileostomy. Port placement mirrors robotic kidney transplantation to promote procedural standardization.ResultsEarly experiences from high-volume centers demonstrate technical feasibility of RPT. Published series report successful implementation without routine need for hand assistance, and institutional experience supports reproducibility. Data remain limited, however, and are not powered to assess comparative outcomes or cost-effectiveness.ConclusionsA standardized approach to RPT is technically feasible and may reduce the surgical burden associated with open SPKT. While larger multicenter studies are required to define safety, graft outcomes, and economic impact, dissemination of a reproducible operative framework represents an essential first step toward broader adoption.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12893-026-03860-w.Keywords: Robotic pancreas transplantation, Simultaneous pancreas-kidney transplant, Pancreas-after-kidney transplant, Pancreas-transplant-alone, Robotic transplant Introduction Therapeutic interventions for diabetes mellitus have evolved dramatically over the past several decades, driven by advances in technology such as continuous glucose monitoring, insulin pumps, and the “artificial pancreas” [1]. Pancreas transplant, however, remains the only definitive therapy that is capable of restoring endogenous insulin secretion and normal glycemic physiology, and has been defined as “life-saving” per the First World Consensus Conference on Pancreas Transplantation [2, 3]. Paradoxically, pancreas transplantation has experienced a decline in utilization in the United States [4]. Most patients on the pancreas waiting list are listed for simultaneous pancreas-kidney transplant (SPKT), but the open SPKT has been associated with substantial perioperative morbidity, despite eliminating the burden of diabetes as well as dialysis for patients who need it [4, 5]. The pancreas transplant is deemed a challenging operation because of concerns regarding large midline incisions, prolonged ileus, intra-abdominal infections, vascular thrombosis, need for anticoagulation and bleeding, and wound complications [6]. While long-term pancreas graft survival remains achievable, [7] durability declines over decades of follow-up, reinforcing the importance of optimizing early surgical outcomes. As a result of dampened enthusiasm, the number of annual pancreas transplants performed has fallen, with only few centers performing > 10 cases per year [8]. There is, however, an opportunity for a re-birth of pancreas transplant. As seen with robotic kidney transplantation (RKT), the presence of robotics in transplant surgery has been transformative, offering reduced surgical trauma, improved recovery, and expanded access for patients with obesity and higher surgical risk [9–11]. The dissemination of RKT has created an unprecedented opportunity to innovate pancreas transplantation using the same minimally invasive principles. We hypothesize that a fully robotic, standardized approach to pancreas transplantation can reduce surgical morbidity, improve patient acceptance, and ultimately reinvigorate this dwindling operation. The objective of this manuscript is to describe a reproducible, step-by-step surgical technique for robotic pancreas transplantation (RPT). Patient selection and indications Patients are considered for RPT either as part of robotic SPKT, through pancreas-after-kidney transplantation, or pancreas transplant alone, with SPKT being the most common in America [4]. Evaluation is performed using a standard, multidisciplinary selection process. Eligible candidates included patients with type 1 diabetes mellitus, as well as those with type 2 diabetes mellitus requiring insulin therapy. Based on renal function, patients were selected for SPKT if uremic, for pancreas-after-kidney (PAK) transplantation if post-uremic, and for pancreas transplant alone (PTA) if pre-uremic and suffering from unstable diabetes or rapidly progressing diabetic complications. All candidates need to meet criteria for pancreas transplantation and be approved by a selection committee including transplant surgery, nephrology, anesthesia, and psychiatry [12]. Preoperative vascular imaging should be obtained in all candidates to assess iliac vessel caliber, calcification, and suitability for vascular anastomosis. It should be noted that patients with extensive vascular calcification may not be candidates for robotic transplant. Patients with obesity should not intentionally be excluded from the preoperative process of listing, with reports indicating that the robotic avenue can be of benefit even in patients with higher body mass index (BMI) [13]. Algorithmic approach to transplant listing A simplified theoretical framework is proposed to simplify the process of waitlisting patients for pancreas transplant (Fig. 1). Briefly, at the time of waitlisting, if a living donor kidney is available, then an RKT should be performed. After RKT, the patient should be put on the transplant waitlist for a pancreas-after-kidney transplant. The pancreas transplant can utilize the same lower abdominal incision made in the RKT, which reduces the burden of cumulative surgical trauma. If there is no living donor kidney available at the time of initial listing, however, then the patient should be listed for SPKT. Other patients may have already received a living or deceased donor kidney transplant and become candidates for PAK, or may suffer from unstable diabetes and/or rapidly progressing diabetic complications despite intact or preserved native renal function, thus becoming candidates for PTA. Conceptual framework for waitlisting patients in need of both a pancreas and kidney transplant for any relevant etiology Operative approach for robotic pancreas transplant There are multiple approaches to performing the pancreas transplant. Some centers perform “head up” positioning, where the pancreas is placed with the head facing the upper abdomen to prioritize enteric drainage from the pancreas to the bowel, while others perform “head down” positioning, with the head of the pancreas facing the bottom of the pelvis [14]. Other operative variations include the placement of the kidney and pancreas in SPKT: while the pancreas is typically placed on the right side, with the kidney on the left for the open approach, [14] variations exist where this is reversed or both are placed on the right side. Typically, in the robotic approach, the orientation is reversed. A large Brazilian experience by Perosa and colleagues, consisting of 1,073 pancreas transplants, highlighted various anastomotic techniques, including enteric anastomoses to the bladder, native duodenum, jejunum, or the terminal ileum [15]. Though this variability does exist, we will not be discussing these, as the purpose of this manuscript is to present a technique utilized by American transplant centers with high volume, such as University of Illinois at Chicago: pancreas on the left side, head down, kidney on the right side, and with a duodenal anastomosis to the ileum [13]. Table 1 presents core steps of the operation, including necessary tenets of the surgical approach and steps that may be subject to surgeon or institutional variability. Table 1Standardized steps for robotic pancreas transplant, with designation of core principles and steps that may differ due to institutional or surgeon preferenceOperative Step NumberStep NameNecessity1Preparation of the Sutures and Back-Table Preparation of the GraftCore Principle: Care should be taken to ensure that the graft has been meticulously cleaned and that any bleeding vessels are appropriately cauterized with electro-cautery. A donor iliac Y-graft should also be made at this time.2Dissection of the Left Iliac Vessels Core Principle 3Positioning the Pancreas GraftCore Principle: This should be done with the pancreas on the left side and head-down, as this allows for optimal venous outflow, preventing blood stasis and the formation of blood clots4Venous AnastomosisCore Principle: Venous anastomosis should be performed before the arterial anastomosis5Arterial Anastomosis Core Principle 6Reperfusion and Hemostasis Subject to Variation 7Duodenal-Enteric AnastomosisSubject to Variation: Either a side-to-side anastomosis (presented here) or Roux-en-Y enteric anastomosis can be performed Standardized steps for robotic pancreas transplant, with designation of core principles and steps that may differ due to institutional or surgeon preference The procedure starts with the introduction of a Veress needle into the left upper quadrant, with insufflation to 12–15 mmHg. A representation of robotic arm placement is presented in Fig. 2. All ports placed for the procedure are 8 mm ports. The camera is placed in robot arm 3, which is placed around 20 centimeters from the iliac vessels. It may be at or above the umbilical scar. For reference, this is typically the highest point upon insufflation. For patients with high BMI, a midline incision is made here with a GelPoint™ (Applied Medical, Rancho Santa Margarita, CA) placed, or a robotic trocar is placed for patients with lower BMI. The active right hand is placed in robot arm 4, which is placed 8 centimeters lateral to arm 3 on the patient’s right flank. It is placed either directly in-line with arm 3 or 1 centimeter inferior for visualization of the remaining robotic instruments upon entry. The active left hand is placed in robot arm 2, placed to mirror arm 4. Thus, it is around 8 centimeters lateral to arm 3 and placed in the patient’s left flank. Robot arm 1 is an additional assist port, placed as lateral as possible on the left flank, ≥ 8 centimeters from arm 2. An alternative approach to arm placement would be to place arm 1 prior to placing arm 2 and then placing arm 2 equidistant between arms 1 and 3. Lastly, a laparoscopic 15 mm assist port is placed, lateral to arm 3 in the GelPOINT for patients with high BMI, or in the Pfannenstiel incision for patients with low BMI. Representation of port placement in robotic pancreas kidney transplant for patients without (A) and with obesity (B). Numbered ports indicate robotic trocar placement. The green port marked with an “L” indicates a laparoscopic assist port. The GelPOINT (blue) is marked with a “G”. The Pfannenstiel incision (A) is indicated at the site of GelPOINT placement While we do not aim to provide a detailed description of the donor procedure here, we should emphasize that meticulous surgical dissection is crucial, as bleeding in robotic pancreas transplantation is better prevented than controlled. Aside from docking the robot, the procedure can be marked in seven distinct steps (Fig. 3; Supplemental Video), as outlined below: Step-by-step approach to the robotic pancreas transplant, including (A) suture and graft preparation, (B) iliac vessel dissection, (C) pancreas graft positioning, (D) venous anastomosis, (E) arterial anastomosis, F-G) reperfusion of the graft and hemostasis, and H-I) duodenal-enteric anastomosis Preparation of the sutures and back-table preparation of the graft Preparation of the sutures and back-table preparation of the graft The pancreas graft is prepared on the back-table (Fig. 3A). A donor iliac artery Y-graft, as described in prior literature, [15] is constructed to provide a single arterial inflow, anastomosed to the donor superior mesenteric and splenic arteries. The portal vein is inspected for length and quality. A donor iliac vein extension graft is prepared and used selectively to ensure a tension-free venous anastomosis in case the donor portal vein is not long enough to anastomose with the recipient venous system. Excess peripancreatic fat is trimmed with the use of a LigaSure™ bipolar electrosurgical device (Medtronic, Minneapolis, Minnesota), while preserving capsular integrity and vascular pedicles. The donor duodenum was shortened with staplers, to an appropriate length (preserving only the 2nd portion) to facilitate enteric drainage without redundancy. A final flush with methylene blue is performed to identify potential sources of bleeding that can be addressed at the back-table. Meticulous surgical dissection is crucial to prevent intraoperative bleeding. Robotic sutures are prepared in advance, including running nonabsorbable monofilament sutures for vascular anastomoses and absorbable barbed or braided sutures for the enteric anastomosis. Suture lengths are standardized to 16 cm for the venous anastomosis and 14 cm for the arterial anastomosis to avoid intracorporeal exchanges during critical steps. In the early experience, two sutures were used, each at half the respective length for either anastomosis, and tied together. This was done for efficiency, as it reduced the number of knots necessary to be done robotically. 2.Dissection of the left iliac vessels Dissection of the left iliac vessels After robotic docking, the peritoneum overlying the iliac vessels is incised, and the external iliac artery and vein are exposed using sharp and blunt dissection (Fig. 3B). Vessel loops are placed circumferentially around the artery (proximally and distally) to allow controlled mobilization and to facilitate assessment of vessel quality. Particular attention is paid to identifying areas of calcification and selecting an anastomotic site with compliant arterial wall. When implantation is planned on the left side, the left iliac vessels were dissected with care to preserve surrounding structures. For right-sided pancreas implantation (e.g., pancreas-after-kidney transplantation), the external iliac artery is medialized as needed to reduce tension on the arterial anastomosis. Hemostasis is meticulously secured before graft introduction. The key component of this dissection is to limit it to a vascular area with adequate target for the anastomosis, the “triangle operation”, within the following limits: medially, the native ureter; laterally, the genitofemoral nerves (and/or the spermatic cord in males); and lastly, the obliterated umbilical vein (and/or the vas deferens in males). This limited dissection allows excellent exposure of the structures of interest, without excessive dissection and increased complications from that. Additionally, the use of vessel loops encircling the artery, gently moving it along its extension, is useful to identify areas of the vessel without calcification as targets for clamping, facilitating streamlined arterial anastomoses later in the procedure. It is also important to perform a lymph node dissection in obese patients, resecting the lymph nodes inside this triangle, with a bipolar dissection device to avoid the development of postoperative lymphoceles. 3.Positioning the pancreas graft Positioning the pancreas graft The pancreas graft is introduced through the lower abdominal incision using a Z-fold quick clot jacket (Teleflex, Wayne, Pennsylvania). Under robotic visualization, the graft is oriented with the head positioned inferiorly (“head-down”), allowing a straight, non-angulated course of the portal vein to the external iliac vein. The graft is positioned extraperitoneally within the iliac fossa (Fig. 3C). Final graft orientation is confirmed before proceeding with vascular anastomoses, with particular attention to avoiding torsion of the vascular pedicle and compression of the graft by surrounding structures. 4.Venous anastomosis Venous anastomosis A 2,000 IU bolus of intravenous heparin is administered prior to vascular cross-clamping. The external iliac vein is clamped proximally and distally using robotic straight Bulldog clamps (Scanlan International, Inc., St. Paul, Minnesota). A longitudinal venotomy is created (Fig. 3D), and an end-to-side anastomosis between the donor portal vein (or portal vein extension graft) and the external iliac vein is performed using a running #CV-5 GoreTex sutures (Gore Medical, Newark, Delaware). Care is taken to maintain precise spacing and consistent bite depth to ensure a hemostatic anastomosis. Then a bulldog clamp is placed in the portal vein, and the external iliac vein clamps are released sequentially to assess for bleeding and to confirm unobstructed venous outflow. 5.Arterial anastomosis Arterial anastomosis The external iliac artery is clamped with two straight robotic Bulldog clamps, and an arteriotomy is created at the preselected site, free from calcification (Fig. 3E). An arteriotomy is made after a single stitch is applied with full thickness bite at the arterial wall and lifted anteriorly to allow the arteriotomy with robotic scissors without arterial dissection. Following arteriotomy, the artery is flushed to remove clots. A single end-to-side arterial anastomosis is performed between the donor Y-graft and the external iliac artery using a running #CV-6 GoreTex sutures. This strategy simplified arterial reconstruction and minimized warm ischemia time. A robotic bulldog clamp is then applied to the Y-graft artery, and the external iliac artery clamp is released in a controlled fashion, and the anastomosis is inspected for bleeding and pulsation. 6.Reperfusion and hemostasis Reperfusion and hemostasis After sequential release of the vascular clamps, the pancreas graft is reperfused (Fig. 3F). Immediate visual assessment confirms uniform graft perfusion, color change, and absence of venous congestion. Indocyanine green (ICG) is then utilized to ensure appropriate blood flow (Fig. 3G). Hemostasis at the vascular anastomoses is verified under low pneumoperitoneum pressure to avoid masking bleeding. Any minor oozing is addressed robotically with additional sutures or hemostatic agent adjuncts as needed. The graft is re-evaluated to ensure that final positioning remained optimal following reperfusion. 7.Duodenal-enteric anastomosis Duodenal-enteric anastomosis Enteric drainage is quickly established using a side-to-side duodeno-ileostomy. The segment of the terminal ileum that reaches the donor duodenum without tension is selected. Enterotomies are created in the donor duodenum and recipient ileum (Fig. 3H), and a side-to-side anastomosis is performed using a running #4 − 0 STRATAFIX™ PDS suture (Johnson and Johnson, New Brunswick, New Jersey) in a two-layer fashion. An alternative is to perform the anastomosis using robotic staplers, only closing the corner opening with the same suture. The anastomosis is inspected for tension, patency, and hemostasis (Fig. 3I). The bowel is returned to its anatomic position, ensuring that the graft and anastomosis lay without kinking or compression. One final test with ICG is performed to ensure appropriate perfusion of the graft. Operative approach for robotic kidney transplant after pancreas implantation Standardized steps for the RKT procedure after pancreas implantation are the same as those for RKT that have been described in prior literature. [16, 17] This manuscript will not outline the procedural steps for this reason. It should be noted that some centers may utilize a “hybrid” approach to the SPKT, where the pancreas transplant is performed robotically, and the kidney transplant is performed via an open approach to reduce operative time. However, with the successes of RKT and the ability to keep the same incisions with the robotic approach, the RKT should be utilized to avoid any morbidity associated with initiating an open kidney transplant. The order of the arm placement for the RKT is the same as for the RPT. Postoperative management Postoperative management for robotic SPKT is similar to management in open cases. Management is typically marked by immunologic and metabolic monitoring (routine C-peptide trending), early detection of vascular complications, and preservation of graft perfusion. Splenic or portal vein thrombosis remains the leading cause of early graft loss, with Blundell and colleagues presenting a rate of 7.1% in a meta-analysis. [18] Many centers employ protocols with heparin for up to 72 h post-transplant, [19] with routine early ultrasound (immediately post-transplant as well as daily for the first three days) to ensure arterial and portal venous patency. Metabolic monitoring is equally important. Insulin independence is expected in a functioning pancreas transplant, and frequent glucose monitoring serves as an early surrogate marker of perfusion or rejection [20]. Routine glucose drips are utilized in light of new endogenous insulin production to prevent hypoglycemia in the postoperative period. Maintenance of adequate mean arterial pressures prevents hypoperfusion to the grafts. For immunologic management, lymphocyte depleting induction followed by tacrolimus-based therapy is supported by the First World Consensus Conference on Pancreas Transplantation [3]. The immunosuppressive regimen is changed to sirolimus after 1 month. Early published clinical outcomes Robotic pancreas transplant was first described by Boggi and colleagues in 2012, with initial 3 cases [21]. However, broad dissemination was limited at that time. Contemporary experiences include 21 cases from the University of Illinois Chicago (16 with one year follow-up), and four cases reported by the Miami Transplant Institute, demonstrating technical feasibility and acceptable early outcomes [12, 13]. At the University of Illinois Chicago, [13] patients undergoing robotic SPKT had a higher BMI (median 34.9 vs. 28.1, p < 0.001) and higher cardiac risk (ejection fraction < 45% 43.8% vs. 6.5%, p < 0.001). Operative time was significantly longer (median 494 vs. 348 min, p < 0.001), as was warm ischemia time for the pancreas (54 vs. 30 min, p < 0.001) and kidney (52 vs. 41 min, p < 0.001). In spite of this, length of stay, rates of 30-day reoperation and readmission, 30-day surgical complications, and pancreas, kidney, and patient survival at one year of follow up did not significantly differ. Importantly, when they performed a BMI-matched analysis, limiting their open cohort to 16 cases matched to the robotic ones, postoperative outcomes were similar as well, highlighting that the robotic approach is safe for patients with higher BMI. The University of Miami experience was also positive [12]. Though they did not have a comparison group, they presented a median operative time of 467.5 min, and pancreas and kidney warm ischemia times of 67 and 57 min, respectively. No patients in their report experienced adverse surgical complications, and there were no episodes of pancreas allograft thrombosis or rejection. They stated that all patients achieved insulin independence at 3 months post-transplant with appropriate renal function. An additional case using an identical technique has been performed internationally, supporting reproducibility. These results have not been published, however. Discussion Pancreas transplantation remains the only definitive biological cure for diabetes mellitus, yet its utilization has steadily declined due to substantial morbidity associated with the procedure [6]. These surgical burdens, coupled with modest long-term pancreas graft survival relative to kidney transplantation alone, have contributed to decreasing national volumes and increasing concentration of pancreas transplantation within a small number of high-volume centers [8]. In this context, the emergence of robotic surgery platforms may serve as an opportunity to fundamentally reframe the surgical risk-benefit profile of pancreas transplantation. The transition from an open to robotic simultaneous pancreas-kidney transplantation represents a conceptual shift rather than purely technical modification. Robotic surgery has been shown to offer improved three-dimensional visualization, tremor filtration, and wristed instrumentation that enables precise vascular reconstruction in confined spaces [22]. Especially since early complications of pancreas transplantation are driven by vascular complications, [18, 23] the enhanced performance in robotic surgery may circumvent these concerns. Additionally, the robotic platform allows for much higher magnification (up to 10x) compared to standard loupes utilized in open surgery (around 2.5x), which may aid in creating vascular anastomoses [24, 25]. The robotic platform also facilitates meticulous optimization of graft orientation and venous geometry, allowing tension-free portal vein anastomoses and liberal use of venous extension grafts when needed. While it has not been studied specifically in robotic pancreas transplantation, these principles are associated with improved outcomes in open pancreas transplantation [12, 26]. In gastrointestinal and colorectal surgery, it has been noted that the robotic approach is associated with minimal unnecessary bowel manipulation [27–29]. The experience presented at the University of Illinois Chicago indicates that this holds true even in the setting of transplant surgery, even with their hand-assisted approach [13]. This is especially relevant in patients with diabetes, who are at higher risk of gastroparesis or issues with postoperative bowel motility [30]. While pancreas-specific data remain limited, the shared surgical drivers of postoperative morbidity provide a biologically plausible rationale for similar benefits in robotic pancreas transplantation. Pancreas transplantation has been characterized by substantial technical heterogeneity, encompassing graft orientation, laterality, arterial reconstruction, and exocrine pancreas drainage strategies [13, 31, 32]. Though this flexibility allows for individualizable operations and surgeon-specific decision making, it also introduces variability in operative technique that may hinder reproducibility and dissemination. In this manuscript, we intentionally describe and rationalize a single, standardized operative strategy that has proven to be successful [12]. Central tenets to this approach are implantation of the pancreas with the head oriented inferiorly on the left side, allowing for a straight, tension-free portal vein anastomosis, and the use of a Y-graft to simplify arterial inflow and reduce warm ischemia time of the pancreas (Table 1). With the heterogeneity of operative approaches, it is difficult to assume that outcomes will be homogenous. More work needs to be done to not only optimize the procedure, but also to prove its safety and ensure that dissemination is done in an appropriate manner. Operative sequencing in the robotic SPKT remains an area of debate. A pancreas-first strategy may be justified by the increased sensitivity to ischemia of the pancreas relative to the kidney, presenting as an increased risk of ischemia reperfusion injury [33, 34]. Adjunct technologies, such as regional hypothermia devices and ex-vivo perfusion platforms, [35, 36] may influence discussion about operative sequence in the future. Importantly, the advent of the robotic platform can allow for either pancreas- or kidney-first implementation, enabling centers to tailor sequencing based on ischemia considerations and institutional preferences. Certain components of this procedure trend towards intra-operative optimization. The arterial Y-graft is helpful in reducing warm ischemia time of the implanted pancreas. From a surgical standpoint, it simplifies the procedure by necessitating only one arterial anastomosis. Secondly, the use of long trocars allows more space outside of the abdominal cavity for the active arms and avoids conflicts or collisions between the robotic arms, which is especially helpful in patients with low BMI. The adoption of robotic pancreas transplantation is inherently dependent on operative teams. Experience from robotic kidney transplant demonstrates that case volume and perioperative workflows are improved once standardization is complete and consistent operating room and postoperative care teams are established [17, 37]. Analyses of robotic kidney transplant learning curves suggest that approximately 25–40 robotic kidney transplants are required to achieve technical mastery of the procedure and stable operative performance [38]. It is likely that this procedure would benefit from prior mastery in other robotic surgeries, such as kidney transplant, as well as performing a large number of open SPKTs per year. The bedside assistant also plays a particularly critical role in the fully-robotic approach, managing graft introduction, suction, and exposure, which are known to be helpful across robotic surgery [39, 40]. Patient selection is paramount during early adoption and should be viewed as an important risk mitigation strategy. Initial candidates should ideally have a BMI < 30 kg/m2, minimal iliac vessel calcification, favorable donor anatomy, and limited prior abdominal surgery [12, 41]. These criteria allow teams to focus on mastering robotic workflows and vascular reconstruction while minimizing confounding technical challenges. Though anecdotally, robotic kidney transplant has increased access to care for patients with higher BMI, [10, 11, 17] it is important that the initial experience with robotic pancreas transplant at any institution should be streamlined as much as possible. The robotic platform can also aid in identifying calcified plaques intraoperatively through the use of vessel loops and guide arteriotomy placement, compensating partially for the lack of tactile feedback. Psychosocial considerations may also influence the perceived value of robotic pancreas transplantation. Younger patients may prioritize cosmesis, rapid recovery, and early return to baseline activity. Avoiding a large midline incision has been associated with patient satisfaction in minimally-invasive transplant surgery [42, 43]. While these benefits are speculative in kidney transplantation and require analysis in future studies, they may improve patient acceptance of the procedure in early dissemination or adoption. The decline in pancreas transplantation has occurred in parallel with rapid advances in diabetes technology, including continuous glucose monitoring, insulin pumps, and hybrid closed-loop systems. [1] Although these technologies improve glycemic control and quality of life, they do not replace endogenous insulin secretion [44, 45]. Alternative biological strategies, such as islet cell transplantation, have demonstrated limited durability, with most recipients experiencing graft failure within 5–6 years, [46–48] while stem cell-derived pancreatic implants remain investigational [49, 50]. The persistence of these approaches underscores the absence of a durable, low-morbidity biological cure and highlights the potential relevance of a less invasive surgical platform for pancreas transplantation. While surgical intervention may be the way to restore physiological function to the patient in lieu of diabetes-centered technological advances, it is not easy to implement robotics programs at hospitals. Historically, robotic platforms entail higher intraoperative and upfront costs compared to traditional open approaches, [51] driven by longer operative times and per-case instrumentation costs. While it is possible that reductions in complications, shorter length of stay, and lower readmission rates may offset this initial cost, there are no direct cost-benefit analyses for robotic SKPT. Comparable analyses of open versus robotic pancreatectomies, however, do show that the robotic procedure is associated with decreased overall costs up to 30 days post-operation [52]. This study has important limitations. The number of robotic pancreas transplants performed to date is small and insufficient to support definitive conclusions regarding comparative outcomes, graft survival, or cost-effectiveness. However, the primary objective of this manuscript is to describe a reproducible surgical technique, not to report postoperative outcomes. Extrapolation of benefits observed in robotic kidney transplantation must be made cautiously, as pancreas transplantation introduces distinct immunologic and metabolic considerations. Nonetheless, the technical drivers of surgical morbidity, incision burden, bowel manipulation, and vascular precision, are shared across abdominal transplant procedures, providing a rational basis for cautious extrapolation. Conclusions This technical review highlights a reproducible approach to robotic pancreas transplant, especially in centers that have already incorporated robotic kidney transplant. While the technique has not been studied extensively, many of the benefits seen in robotic surgery at-large may increase enthusiasm for the dissemination of this technique. Future research should prioritize prospective, multicenter collaboration to evaluate safety, reproducibility, and early outcomes using standardized reporting metrics. Longitudinal follow-up will be essential to determine whether reductions in surgical morbidity translate into improved graft survival, quality of life, and cost-effectiveness. Importantly, dissemination of a standardized, reproducible robotic technique, as described here, represents a necessary first step toward generating the evidence required to define the role of robotic pancreas transplantation in modern diabetes care. Supplementary Information Supplementary Material 1. Acknowledgements Not applicable. Abbreviations Body mass index Indocyanine green Robotic kidney transplantation Robotic pancreas transplantation Simultaneous pancreas–kidney transplantation Authors’ contributions PA and HK conceptualized the study, performed narrative synthesis, and visualization for the manuscript. PA, HK, and SZ wrote the initial draft of the manuscript, with input from GG, GOG, MCN, ASK, ME, JR, JF, RV, DB, UB, and MS. All authors (PA, HK, SZ, GG, GOG, MCN, ASK, ME, JR, JF, RV, DB, UB, and MS) reviewed and approved the final version of this manuscript. Funding Not applicable. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate As this work did not include outcomes data, it posed no risk to patients. As a technical paper and overview of the current landscape of robotic pancreas transplant, IRB approval was not required. Consent for publication Not applicable. Competing interests Drs. Phillipe Abreu, Adeel Khan, and Mario Spaggiari consult for Intuitive Surgical, Inc. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Phillipe Abreu and Haaris Kadri contributed equally to this work as first authors. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement No datasets were generated or analysed during the current study.